BACKGROUND AND OBJECTIVES: The complement cascade seems to be an important mediator modulating renal ischemia/reperfusion injury. This study analyzed whether significant changes occur in the levels of a terminal panel of complement molecules (C3a, C5a, and C5b-9/membrane attack complex) during the early phase of human kidney allograft reperfusion and evaluated the potential association of these changes with clinical post-transplant graft function in kidney transplant recipients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Seventy-five renal transplant recipients undergoing transplantation between 2004 and 2006 were enrolled in the study and divided into early, slow, and delayed graft function groups. Blood samples were collected perioperatively during consecutive minutes of allograft reperfusion from the renal vein. Levels of complement molecules were measured using ELISA. RESULTS: Analysis revealed no significant changes in C3a and C5a levels throughout reperfusion. The main complement molecule that was significantly associated with post-transplant graft function was C5b-9/membrane attack complex; throughout the reperfusion period, perioperative levels of C5b-9/membrane attack complex were around two to three times higher in delayed graft function patients than early and slow graft function individuals (P<0.005). In addition, C5b-9/membrane attack complex levels had a relatively high clinical sensitivity and specificity (70%-87.5%) for the prediction of early and long-term (1 year) post-transplant allograft function. CONCLUSIONS: This clinical study supports a role for the complement cascade in delayed graft function development. However, additional studies are needed to elucidate the exact mechanisms responsible for this phenomenon. In addition, perioperative measurements of C5b-9/membrane attack complex are highlighted as promising potential clinical markers of post-transplant renal allograft function.
BACKGROUND AND OBJECTIVES: The complement cascade seems to be an important mediator modulating renal ischemia/reperfusion injury. This study analyzed whether significant changes occur in the levels of a terminal panel of complement molecules (C3a, C5a, and C5b-9/membrane attack complex) during the early phase of human kidney allograft reperfusion and evaluated the potential association of these changes with clinical post-transplant graft function in kidney transplant recipients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Seventy-five renal transplant recipients undergoing transplantation between 2004 and 2006 were enrolled in the study and divided into early, slow, and delayed graft function groups. Blood samples were collected perioperatively during consecutive minutes of allograft reperfusion from the renal vein. Levels of complement molecules were measured using ELISA. RESULTS: Analysis revealed no significant changes in C3a and C5a levels throughout reperfusion. The main complement molecule that was significantly associated with post-transplant graft function was C5b-9/membrane attack complex; throughout the reperfusion period, perioperative levels of C5b-9/membrane attack complex were around two to three times higher in delayed graft function patients than early and slow graft function individuals (P<0.005). In addition, C5b-9/membrane attack complex levels had a relatively high clinical sensitivity and specificity (70%-87.5%) for the prediction of early and long-term (1 year) post-transplant allograft function. CONCLUSIONS: This clinical study supports a role for the complement cascade in delayed graft function development. However, additional studies are needed to elucidate the exact mechanisms responsible for this phenomenon. In addition, perioperative measurements of C5b-9/membrane attack complex are highlighted as promising potential clinical markers of post-transplant renal allograft function.
Authors: A Humar; E M Johnson; W D Payne; L Wrenshall; D E Sutherland; J S Najarian; K J Gillingham; A J Matas Journal: Clin Transplant Date: 1997-12 Impact factor: 2.863
Authors: L Domański; B Dołegowska; K Safranow; J Rózański; M Myślak; M Romanowski; J Sieńko; T Sulikowski; M Ostrowski; K Kedzierska; M Domański; D Chlubek; A Pawlik; K Ciechanowski Journal: Clin Transplant Date: 2006 Jan-Feb Impact factor: 2.863
Authors: Anna Deskur; Daria Sałata; Marta Budkowska; Barbara Dołęgowska; Teresa Starzyńska; Wojciech Błogowski Journal: Am J Transl Res Date: 2014-11-22 Impact factor: 4.060
Authors: Katarzyna Waszczuk; Jolanta Kucharska-Mazur; Ernest Tyburski; Katarzyna Rek-Owodziń; Piotr Plichta; Krzysztof Rudkowski; Piotr Podwalski; Tomasz Grąźlewski; Monika Mak; Błażej Misiak; Anna Michalczyk; Maciej Tarnowski; Katarzyna Sielatycka; Angelika Szczęśniak; Karolina Łuczkowska; Barbara Dołęgowska; Marta Budkowska; Mariusz Z Ratajczak; Jerzy Samochowiec Journal: Int J Environ Res Public Health Date: 2022-05-15 Impact factor: 4.614
Authors: Wojciech Błogowski; Anna Deskur; Marta Budkowska; Daria Sałata; Anna Madej-Michniewicz; Krzysztof Dąbkowski; Barbara Dołęgowska; Teresa Starzyńska Journal: PLoS One Date: 2014-05-21 Impact factor: 3.240
Authors: Carlos Arias-Cabrales; Eva Rodriguez-Garcia; Javier Gimeno; David Benito; María José Pérez-Sáez; Dolores Redondo-Pachón; Anna Buxeda; Carla Burballa; Marta Crespo; Marta Riera; Julio Pascual Journal: J Clin Med Date: 2021-03-02 Impact factor: 4.241
Authors: Wojciech Blogowski; Katarzyna Dolegowska; Anna Deskur; Barbara Dolegowska; Teresa Starzyńska Journal: Medicine (Baltimore) Date: 2015-08 Impact factor: 1.817